KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹42 Cr | ₹43 Cr | ₹34 Cr | ₹-33 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of KOPRAN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹60 Cr |
How is Cash Flow from Operating Activities of KOPRAN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | -3.04 | |
| Mar2024 | ₹43 Cr | 27.14 | |
| Mar2023 | ₹34 Cr | Positive | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹618.5 Cr | -2.2% | -3.7% | -39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.2% |
-3.7% |
-39.8% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses